Floatz logo

E-selectin

Cerebrovascular Accident

National Institute of Neurological Disorders and Stroke (NINDS)Phase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Cerebrovascular Accident cohort.

Asset / SponsorPhaseRating
Aggrenox
Boehringer Ingelheim
Phase 4BBB
ADVICOR COMPONENT NIACIN
Axio Research. LLC
Phase 4BB
Benserazide
University Hospital Muenster
Phase 4BB
CANDESARTAN
Population Health Research Institute
Phase 4BB
VALSARTAN
Stanford University
Phase 4BB

View all 34 →

Same molecule, other indications

E-selectin is also rated in:

transient ischemic attackDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →